2014.1-8 FDA approved drug

2014.1-8 FDA approved drug

No.	Drug Name	Active Ingredient	Date	What It’s Used For
23.	Orbactiv	oritavancin	8/6/2014	To treat adults with skin  infections * k0 F! ?5 o. E: z. ~' i  Press Release
22.	Jardiance	empagliflozin	8/1/2104	To improve gylcemic control  in adults with type 2 diabetes / k; c# S& U4 I+ Z( q6 M  Press Release
21.	Striverdi  Respimat	olodaterol	7/31/2014	To treat chronic obstructive  pulmonary disease   Press Release
20.    ' O# |; h$ ]5 h* a$ H' c	Zydelig	idelalisib	7/23/2014	To treat patients with trhee  types of blood cancers   Press Release
19.	Kerydin ( p6 m: [8 E. y, E8 H   + o5 n2 S) p+ \4 u* ~+ g	tavaborole	7/7/2014	For the topical treatment of  onychomycosis of the toenails   (No Press Release)
18.	Beleodaq	belinostat	7/3/2014	To treat patients with  peripheral T-cell lymphoma (PTCL) * U$ W; t% E& @; r  Press Release
17.	Sivextro (tablet)Sivextro  (injection)	tedizolid phosphate	6/20/2014	To treat adults with skin  infections   Press Release
16.	Jublia : p9 o( ], e, v8 @9 M0 e; Y% T& D1 B	efinaconazole	6/6/2014	Treat mild to moderate  onychomycosis (fungal infection) ) G8 N/ p/ z7 W  a' `   No Press Release
15.	Dalvance	dalbavancin	5/23/2014	To treat adults with skin  infections   Press Release
14.	Entyvio % A' z. ]/ |! ?4 M' ^	vedolizumab	5/20/2014	To treat adult patients with  moderate to severe ulcerative colitis and adult patients with moderate to  severe Crohn‘s disease   Press Release
13.	Zontivity	vorapaxar	5/8/2014	To reduce the risk of heart  attacks and stroke in high-risk patients * c! i* K3 ^: {  s6 K  Press Release
12.	Zykadia	ceritinib	4/29/2014	To treat patients with a  certain type of late-stage (metastatic) non-small cell lung cancer (NSCLC) 7 A! q9 Z" K: Q  Press Release
11.	Sylvant	siltuximab	4/23/2014	To treat patients with multicentric  Castleman’s disease (MCD), a rare disorder similar to lymphoma (cancer of the  lymph nodes)   a* ^: ~8 r5 M2 }' ?* D; O0 y  @  Press Release
10.	Cyramza	ramucirumab	4/21/2014	To treat patients with  advanced stomach cancer or gastroesophageal junction adenocarcinoma ; d; v7 _7 W; b- v& n0 l9 ?  Press Release
9.	Tanzeum	albiglutide	4/15/2014	To improve glycemic control,  along with diet and exercise, in adults with type 2 diabetes   Press Release
8.	Otezla	apremilast	3/21/2014	To treat adults with active  psoriatic arthritis (PsA) ) X* r: T$ f" R6 W  Press Release
7.	Impavido	miltefosine	3/19/2014	To treat a tropical disease  called leishmaniasis   Press Release
6.	Neuraceq	florbetaben F 18 injection	3/19/2014	For Positron  EmissionTomography (PET) imaging of the brain
5.	Myalept	metreleptin for injection	2/24/2014	To treat the complications  of leptin deficiency . s2 g  m6 V3 A4 R& m7 d) E: h  Press Release
4.	Northera	droxidopa	2/18/2014	To treat neurogenic  orthostatic hypotension (NOH)   Press Release
3.	Vimizim	elosulfase alfa	2/14/2014	Treatment for Mucopolysaccharidosis Type IVA  (Morquio A syndrome) 9 f* Q( p) d2 Z( z: O; z) \  Press Release
2.	Hetlioz	tasimelteon	1/31/2014	To treat non-24- hour sleep-wake disorder (“non-24”)  in totally blind individuals. Non-24 is a chronic circadian rhythm (body  clock) disorder in the blind that causes problems with the timing of sleep.Press Release
1.	Farxiga	dapaglifozin	1/8/2014	To improve glycemic control,  along with diet and exercise, in adults with type 2 diabetes ) C/ n. F6 U  O& S# s0 n) E  Press Release

" R7 h* e- b; R8 j) v$ K4 W

感谢楼主分享，楼主好强大